DE60003679D1 - Polymorphe eines kristallinen azabicyclo(2,2,2) octan-3-amin citrat und diesen enthaltenden arzneimitteln - Google Patents

Polymorphe eines kristallinen azabicyclo(2,2,2) octan-3-amin citrat und diesen enthaltenden arzneimitteln

Info

Publication number
DE60003679D1
DE60003679D1 DE60003679T DE60003679T DE60003679D1 DE 60003679 D1 DE60003679 D1 DE 60003679D1 DE 60003679 T DE60003679 T DE 60003679T DE 60003679 T DE60003679 T DE 60003679T DE 60003679 D1 DE60003679 D1 DE 60003679D1
Authority
DE
Germany
Prior art keywords
octan
amin
polymorphic
citrate
medicaments containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60003679T
Other languages
English (en)
Other versions
DE60003679T2 (de
Inventor
Michael James Castaldi
George Joseph Quallich
Lewin Theophilus Wint
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Application granted granted Critical
Publication of DE60003679D1 publication Critical patent/DE60003679D1/de
Publication of DE60003679T2 publication Critical patent/DE60003679T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60003679T 1999-06-01 2000-05-18 Polymorphe eines kristallinen azabicyclo(2,2,2) octan-3-amin citrat und diesen enthaltenden arzneimitteln Expired - Lifetime DE60003679T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13699299P 1999-06-01 1999-06-01
US136992P 1999-06-01
PCT/IB2000/000665 WO2000073304A1 (en) 1999-06-01 2000-05-18 Polymorphs of a crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions

Publications (2)

Publication Number Publication Date
DE60003679D1 true DE60003679D1 (de) 2003-08-07
DE60003679T2 DE60003679T2 (de) 2004-05-27

Family

ID=22475338

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60003679T Expired - Lifetime DE60003679T2 (de) 1999-06-01 2000-05-18 Polymorphe eines kristallinen azabicyclo(2,2,2) octan-3-amin citrat und diesen enthaltenden arzneimitteln

Country Status (49)

Country Link
US (1) US6255320B1 (de)
EP (1) EP1181290B1 (de)
JP (1) JP3830816B2 (de)
KR (1) KR100476606B1 (de)
CN (1) CN1146565C (de)
AP (1) AP2001002349A0 (de)
AR (1) AR033331A1 (de)
AT (1) ATE244239T1 (de)
AU (1) AU767334B2 (de)
BG (1) BG65240B1 (de)
BR (1) BR0011094A (de)
CA (1) CA2372238C (de)
CO (1) CO5170463A1 (de)
CY (1) CY2007011I2 (de)
CZ (1) CZ295819B6 (de)
DE (1) DE60003679T2 (de)
DK (1) DK1181290T3 (de)
DZ (1) DZ3050A1 (de)
EA (1) EA003731B1 (de)
EC (1) ECSP003508A (de)
EE (1) EE200100656A (de)
ES (1) ES2199825T3 (de)
GT (1) GT200000087A (de)
HK (1) HK1046284A1 (de)
HN (1) HN2000000077A (de)
HR (1) HRP20010904A2 (de)
HU (1) HUP0201301A3 (de)
IL (1) IL146406A0 (de)
MA (1) MA26742A1 (de)
MX (1) MXPA01012325A (de)
MY (1) MY133508A (de)
NO (1) NO20015848L (de)
NZ (1) NZ515349A (de)
OA (1) OA11956A (de)
PA (1) PA8496101A1 (de)
PE (1) PE20010209A1 (de)
PL (1) PL196046B1 (de)
PT (1) PT1181290E (de)
SI (1) SI1181290T1 (de)
SK (1) SK285820B6 (de)
SV (1) SV2001000093A (de)
TN (1) TNSN00120A1 (de)
TR (1) TR200103473T2 (de)
TW (1) TWI285204B (de)
UA (1) UA66925C2 (de)
UY (1) UY26176A1 (de)
WO (1) WO2000073304A1 (de)
YU (1) YU81101A (de)
ZA (1) ZA200109775B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2337685C2 (ru) 2004-01-30 2008-11-10 Пфайзер Продактс Инк. Антагонисты нейрокининового рецептора nk-1 для выхода из наркоза
AU2005216707A1 (en) * 2004-01-30 2005-09-09 Pfizer Products Inc. Pharmaceutical compositions of neurokinin receptor antagonists and cyclodextrin and methods for improved injection site toleration
US8183230B2 (en) * 2004-01-30 2012-05-22 Pfizer Inc. Antimicrobial preservatives to achieve multi-dose formulation using beta-cyclodextrins for liquid dosage forms
ES2296131T3 (es) * 2004-02-02 2008-04-16 Pfizer Products Incorporated Procedimiento para la preparacion de 1-(2s,3s)-2-bencidril-n-(5-terc-butil-2-metoxibencil)quinuclidin-3-amina.
MX361286B (es) * 2013-03-15 2018-12-03 Pearl Therapeutics Inc Métodos y sistemas para el acondicionamiento de materiales cristalinos de partículas.
CN110577522B (zh) * 2018-06-07 2022-12-27 东莞市东阳光动物保健药品有限公司 马罗匹坦柠檬酸盐新晶型及其制备方法
CN112979639A (zh) * 2019-12-16 2021-06-18 四川科瑞德凯华制药有限公司 一种马罗皮坦新晶型及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK390692A3 (en) * 1991-05-31 1998-02-04 Pfizer Quinuclidine derivatives, preparation method thereof and use
US5393762A (en) * 1993-06-04 1995-02-28 Pfizer Inc. Pharmaceutical agents for treatment of emesis
US5576317A (en) * 1994-12-09 1996-11-19 Pfizer Inc. NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis

Also Published As

Publication number Publication date
PL196046B1 (pl) 2007-11-30
PT1181290E (pt) 2003-09-30
EE200100656A (et) 2003-02-17
UA66925C2 (uk) 2004-06-15
DK1181290T3 (da) 2003-09-29
CY2007011I1 (el) 2010-07-28
EP1181290B1 (de) 2003-07-02
SK17332001A3 (sk) 2002-07-02
SK285820B6 (sk) 2007-09-06
EA003731B1 (ru) 2003-08-28
ZA200109775B (en) 2002-11-28
GT200000087A (es) 2001-11-22
NO20015848D0 (no) 2001-11-30
PL352716A1 (en) 2003-09-08
HUP0201301A2 (en) 2002-08-28
PA8496101A1 (es) 2002-07-30
MY133508A (en) 2007-11-30
CA2372238A1 (en) 2000-12-07
CZ295819B6 (cs) 2005-11-16
OA11956A (en) 2006-04-13
CA2372238C (en) 2006-12-19
AR033331A1 (es) 2003-12-17
ES2199825T3 (es) 2004-03-01
SI1181290T1 (en) 2003-12-31
PE20010209A1 (es) 2001-03-01
TNSN00120A1 (fr) 2005-11-10
HK1046284A1 (en) 2003-01-03
DE60003679T2 (de) 2004-05-27
ATE244239T1 (de) 2003-07-15
CY2007011I2 (el) 2010-07-28
HRP20010904A2 (en) 2003-02-28
ECSP003508A (es) 2002-02-25
SV2001000093A (es) 2001-11-08
BG106204A (en) 2002-07-31
NO20015848L (no) 2001-12-18
US6255320B1 (en) 2001-07-03
CZ20014269A3 (cs) 2002-04-17
MXPA01012325A (es) 2002-07-22
BG65240B1 (bg) 2007-09-28
EP1181290A1 (de) 2002-02-27
BR0011094A (pt) 2002-03-19
KR20020010688A (ko) 2002-02-04
AP2001002349A0 (en) 2001-12-31
HUP0201301A3 (en) 2002-10-28
UY26176A1 (es) 2000-12-29
HN2000000077A (es) 2001-02-02
YU81101A (sh) 2004-07-15
DZ3050A1 (fr) 2004-03-27
KR100476606B1 (ko) 2005-03-18
NZ515349A (en) 2004-03-26
IL146406A0 (en) 2002-07-25
CO5170463A1 (es) 2002-06-27
CN1353711A (zh) 2002-06-12
CN1146565C (zh) 2004-04-21
TR200103473T2 (tr) 2002-04-22
EA200101108A1 (ru) 2002-04-25
WO2000073304A1 (en) 2000-12-07
MA26742A1 (fr) 2004-12-20
AU4424800A (en) 2000-12-18
JP3830816B2 (ja) 2006-10-11
JP2003501354A (ja) 2003-01-14
AU767334B2 (en) 2003-11-06
TWI285204B (en) 2007-08-11

Similar Documents

Publication Publication Date Title
HK1044537A1 (en) 1,4-benzothiazepine derivatives methods for the production thereof, medicaments containing these compounds and the use
HUP0203542A3 (en) 3(5)-amino-pyrazole derivatives, process for their preparation, their use and pharmaceutical compositions containing the same
HUP0203330A3 (en) Pharmaceutical compositions with improved solubility and oral absorptivity, containing benzamide derivatives
IL144501A0 (en) Epothilone derivatives, methods for the preparation thereof and pharmaceutical compositions containing the same
HUP0202100A3 (en) Novel quinuclidine derivatives, process for their preparation and medicinal compositions containing the same
HUP0204157A3 (en) 1,3-dihydro-2h-indol-2-one derivatives, process for preparation of the compounds and pharmaceutical compositions containing the same
DE60045402D1 (de) Silylalkylplatin (IV) Verbindungen und deren Herstellung
IL139480A0 (en) Epothilone derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
HUP9803040A3 (en) Thiazole derivatives, process for the preparation thereof, use thereof and pharmaceutical compositions containing them
IL143577A0 (en) Piperazine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
IL180579A0 (en) Piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them
CY2007011I2 (el) Πολυμορφες ενος κρυσταλλικου κιτρικου αλατος αζαδικυκλο (2,2,2) οκταν -3- αμινης και φαρμακευτικες συνθεσεις τους
EP1509220A4 (de) Pharmazeutische zusammensetzung zur behandlung von seborrhoe mit 4-hydroxy-5-methoxy-4-2-methyl-3(3-methyl-2-butenyl)-2-oxiranyl -1-oxaspiro 2,5 octan-6-on
HUP0102609A3 (en) N-phenyl-n'-phenylpropylpiperazine derivatives and process for the preparation thereof, and pharmaceutical compositions containing them
HUP0200343A3 (en) Phenylalaninol derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0001712A2 (en) 2,3-methano-amino acid derivatives, a process for their preparation and pharmaceutical compositions containing them
HUP0203384A3 (en) Process for the preparation of ketimines
HUP0204149A3 (en) New sulfonyl oxazole amine derivatives, pharmaceutical compositions containing them and process for preparation the compounds
IL149527A0 (en) Process for the preparation of ketimines
HUP9803041A3 (en) Thiazole derivatives, process for the preparation thereof, use thereof and pharmaceutical compositions containing them
HUP0202594A3 (en) Streptogramin derivatives, production thereof and pharmaceutical compositions containing the same
AU2002362911A1 (en) Piperidine derivatives, process for preparation thereof, and pharmaceutical composition for alzheimer's disease containing the same
SI1194415T1 (en) Novel piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same, and a process for their preparation
EP1235806A4 (de) Neue 5-pyrimidincarboxamid-derivate und diese derivate enthaltende pharmazeutische gemische
HUP0100661A3 (en) Salts of paroxetine, process for their preparation and medicaments containing the compounds

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: DERZEIT KEIN VERTRETER BESTELLT